Implants

Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions

Stryker’s PROstep MIS portfolio will be featured at the American Orthopaedic Foot & Ankle Society Annual MeetingKALAMAZOO, Mich.--(BUSINESS WIRE)--Stryker (NYSE:…

6 months ago

Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting

RevoMotion™ Reverse Shoulder System showing smallest diameter threaded glenoid baseplate RevoMotion™ Reverse Shoulder System showing smallest diameter threaded glenoid baseplate…

6 months ago

Tenon Medical(R) Announces Expanded Physician Use of New JIB Instrument Kit for Company’s Catamaran(R) SI Joint Fusion System

Mark H. Stouffer, MD and team from Zion Surgery Center successfully perform multiple Catamaran cases with JIB Instrument Kit in…

6 months ago

Aurora Spine Announces Full Release of its SiLO TFX™ MIS Sacroiliac Joint Fixation System

Carlsbad, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a…

6 months ago

Hemostemix Announces New Publication: How NCP-01 Supports Brain Computer Interfaces

Calgary, Alberta--(Newsfile Corp. - September 12, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce…

7 months ago

Forma Medical Launches OptimalHT the World’s First Minimally Invasive Instrumented Hammertoe Arthrodesis Procedure After 50+ Procedures

CAMP HILL, Pa.--(BUSINESS WIRE)--Forma Medical, an emerging innovator in medical device technologies, announces today the launch of OptimalHT, the world’s…

7 months ago

Occlutech Q2 2023 – Continued strong revenue growth

SCHAFFHAUSEN, CH / ACCESSWIRE / September 05, 2023 / Occlutech Holding AG Occlutech Holding AG (Occlutech) is a leading specialist…

7 months ago

Femasys Inc. Obtains Medical Device Establishment License from Health Canada

ATLANTA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs…

7 months ago

Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN I Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis

Topline Results Expected 1H 2024WATERTOWN, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the…

7 months ago

Mithra prices private placement to raise EUR 20 million in equity

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA…

7 months ago